Global X S&P TSX 60 Index Corporate Class ETF (HXT) 銘柄情報

I am in agreement.I am confusedThe private company is a corporate asset. We own 27.5% of it. If it makes money, 27.5% of the profit is ours. HMBL worthless tech is so worthless, that, that private company and Ybyra just spent a lot of money to acquire a majority interest in that tech and its pate

Convertible Cohen is standing by.....

$$$$IQST$$$$

Regarding:
Compassionate Use:

Lastly, there are currently 74 participants receiving blarcamesine within the Compassionate Use Program, who continued treatment with blarcamesine subsequent completion of respective preceding open-label-extension studies from both ANAVEX®2-73-AD-E

U went short or waiting for lower? Interesting, rug pull, Can u elaborate?

RDAR Filing. See you at .003 for starters. 

https://www.sec.gov/Archives/edgar/data/1384365/000139390525000015/0001393905-25-000015-index.htm

Crypto not looking too good.

gooooooooooooooooooooooooooooooood morning bobber

Tight, I’m starting to think that you are along and his cousin Arnold but not nearly as humorous.

Or you are bipolar.

How can this news take the stock down?

Good morning my little market crashers!

.095 starting to clear ~Rig

I haven't worn pants in 15 years, strictly shorts for me.

geez, it’s going to get ugly. kenny boy, cifu and the rest of their cohorts are going to destroy our markets and probably the global economies just to save their businesses and their criminal ways.

and gensler and the sec helped them.

btw, employees are just as guilt

This shift in Lightwave strategy very simply means it’s up to the Tier 1’s themselves who will be first in the market to capture a huge part of the fast growing optical transceiver market beyond 1.6T with Lightwave’s superior material.
It will be won by the fastest acting companies who have t

Is TWOH. Going to be trading today?

MDGL- Madrigal pre-announces 4thQ and full year sales of Rezdiffra (resmetirom) for MASH. They present on Wednesday at JPM.

Madrigal Pharmaceuticals Announces Preliminary* Fourth-Quarter and Full-Year 2024 Net Sales, Year-End Cash and Total Patients on Rezdiffra
-Preliminary

~LODE with filing...

Nice buy opps again with this one when the dust settles today, .32 area is the 200 ma

http://archive.fast-edgar.com/20250113/ASZ3BQ2CZ222KZZ2222J2ZZZGVMBZ6Q86272/

Print
Share On Facebook

22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, today announced that it stands ready to support the U.S. Food an

Banks getting out of their shorts today. They are running scared
The LBMA is almost out of silver

https://x.com/anavexlifesci/status/1878782124200996928?s=46&t=MnBUeeF7s7bE5aYLaXAnhQ

At least the WAS-TB game was entertaining. TB's center must have had his bell rung. Denver hung on for a half, but you could see early on that Buffalo could move the ball far too easily. GB injuries caught up to them.

https://www.ncpe.ie/icosapent-ethyl-vazkepa/
Sleven,

The 45 day Sprint Discussion deadline to reach an agreement on all issues between Vivos and the FDA review team is likely tomorrow, 14 January 2025. The two month estimate for when the validation of the new sterility process will be completed is 20 January 2025.

Vivos could really mak